CVRx 

$3.01
21
-$0.06-1.95% Thursday 20:00
-$0.06-2.1%Thursday 22:45After hours

Statistics

Day High
3.01
Day Low
2.99
52W High
11.3
52W Low
2.2
Volume
15,036
Avg. Volume
-
Mkt Cap
80.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.57
-0.53
-0.48
-0.44
Expected EPS
-0.495314
Actual EPS
N/A

Financials

-94.1%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
56.65MRevenue
-53.31MNet Income

Analyst Ratings

7.50Average Price Target
The highest estimate is 10.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CVRX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers a wide range of medical devices and therapies, including those for cardiovascular conditions, directly competing with CVRx's heart failure treatment solutions.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific competes in the cardiovascular market, offering products that could be used in similar patient populations as CVRx's devices.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories provides a broad portfolio of medical devices, including heart failure and cardiovascular products, competing with CVRx's offerings.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the broader cardiovascular treatment space alongside CVRx.
Baxter International
BAX
Mkt Cap13.51B
Baxter International offers medical devices and therapies that compete in the broader healthcare and cardiovascular spaces, potentially overlapping with CVRx's market.
Stryker
SYK
Mkt Cap126.84B
Stryker operates in the medical technology field with products that could compete for hospital and clinical attention in the cardiovascular space alongside CVRx.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet, primarily known for orthopedics, has been expanding into other areas of medical devices that could indirectly compete with CVRx.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical device division, offers a range of products that could compete in the cardiovascular health space.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical's robotic-assisted surgical systems, while not directly cardiovascular-focused, represent advanced medical technology competition for operating room resources and investment.

About

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Show more...
CEO
Kevin Hykes
Employees
223
Country
United States
ISIN
US1266381052

Listings

0 Comments

Share your thoughts

FAQ

What is CVRx stock price today?
The current price of CVRX is $3.01 USD — it has decreased by -1.95% in the past 24 hours. Watch CVRx stock price performance more closely on the chart.
What is CVRx stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange CVRx stocks are traded under the ticker CVRX.
Is CVRx stock price growing?
CVRX stock has risen by +2.03% compared to the previous week, the month change is a -45.17% fall, over the last year CVRx has showed a -60.91% decrease.
What is CVRx market cap?
Today CVRx has the market capitalization of 80.19M
When is the next CVRx earnings date?
CVRx is going to release the next earnings report on November 03, 2026.
What were CVRx earnings last quarter?
CVRX earnings for the last quarter are -0.53 USD per share, whereas the estimation was -0.52 USD resulting in a -1.03% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CVRx revenue for the last year?
CVRx revenue for the last year amounts to 56.65M USD.
What is CVRx net income for the last year?
CVRX net income for the last year is -53.31M USD.
How many employees does CVRx have?
As of September 04, 2026, the company has 223 employees.
In which sector is CVRx located?
CVRx operates in the Health & Wellness sector.
When did CVRx complete a stock split?
CVRx has not had any recent stock splits.
Where is CVRx headquartered?
CVRx is headquartered in MINNEAPOLIS, United States.